Unlock instant, AI-driven research and patent intelligence for your innovation.

Amide compound as well as preparation method and application thereof

An amide compound and compound technology, applied in the field of drug preparation, can solve the problems of damage to the nervous system, low biological activity, reduction of animal leukocytes, etc., and achieve the effect of overcoming adverse effects

Inactive Publication Date: 2021-09-24
嘉兴金派特生物科技有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, exogenous interferon is mainly used for interferon, but exogenous interferon has some disadvantages, such as difficult production, low yield, high price and low biological activity
In addition, exogenous interferon has certain toxicity, which can cause adverse effects such as leukopenia, abnormal liver function, and damage to the nervous system in animals, and cause serious losses to livestock production.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Amide compound as well as preparation method and application thereof
  • Amide compound as well as preparation method and application thereof
  • Amide compound as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0057] The present invention also provides a preparation method for the above-mentioned amides, comprising the following steps:

[0058] S101: providing a compound shown in formula (I-1);

[0059]

[0060] Wherein, the compound represented by formula (I-1) can be synthesized using commercially available raw materials or using existing methods.

[0061] It is preferably prepared by the following method:

[0062] S1011: Substituting 5-nitro-6-hydroxy-nicotinic acid and thionyl chloride to prepare 5-nitro-6-chloro-nicotinic acid;

[0063]

[0064] Further, it is preferred that the solvent in step S1011 is DMF, and the amount of thionyl chloride added is 10eq-20eq, more preferably 14eq-16eq.

[0065] Further, the preferred operation of step S1011 is: dissolve 5-nitro-6-hydroxy-nicotinic acid in the solvent, slowly add thionyl chloride dropwise under ice bath, and after the dropwise addition, raise the temperature to 75°C-85°C (preferably 80° C.), after the reaction is com...

Embodiment 1

[0093] Embodiment 1: the preparation of interferon inducer (II)

[0094]Synthesis of 5-nitro-6-chloro-nicotinic acid

[0095]

[0096] At 0-10°C, the compound 5-nitro-6-hydroxy-nicotinic acid (20g, 108.63mmol, 1eq) and SOCl 2 (196.80g, 1.65mol, 120.00mL, 15.23eq) was added dropwise to a mixture of DMF (30mL), and after the addition was complete, the reaction was heated to 80°C and stirred for 1h. After LCMS and TLC (ethyl acetate:methanol=10:1) monitoring reaction is complete, rotary evaporation removes most of SOCl 2 , and then carefully poured into ice water (200mL) to quench, extracted with ethyl acetate (100mL*2) and spin-dried to obtain the compound 5-nitro-6-chloro-nicotinic acid (20g). MS: 203(M+1)

[0097] Synthesis of 5-nitro-6-chloro-nicotinamide

[0098]

[0099] The compound 5-nitro-6-chloro-nicotinic acid (18g, 88.87mmol, 1eq) and SOCl 2 (147.60g, 1.24mol, 90.00mL, 13.96eq) mixture was heated to 80°C and stirred for 1 hour. Rotary evaporation removes m...

Embodiment 2

[0109] Embodiment 2: The experimental research that compound (II) induces piglet to produce interferon

[0110] Materials and methods:

[0111] A total of 24 4-week-old one-time weaned piglets were selected as experimental piglets, and randomly divided into 3 groups with 8 piglets in each group, which were respectively designated as X group, Y group and Z group. Wherein group X is a negative control group, and the test substance is normal saline; Group Y, the test substance is an interferon-inducing agent experimental group, and injects compound (II) at a dose of 0.3 mg / kg; Z group is a positive drug group, and the test substance For polycytidine, a 0.7 mg / kg dose of polycytidine solution was injected. After continuous injection for 2 days, the blood samples of piglets were collected to test the interferon alpha (IFN-α) level in the blood.

[0112] Statistical method:

[0113] SPSS11.5 statistical software was used for statistical analysis, the experimental data was tested ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an amide compound and a preparation method and application thereof. The amide compound has a structure as shown in a formula (I). The amide compound can induce generation of endogenous interferon in an animal body and has the potential of being developed into an antiviral drug.

Description

technical field [0001] The invention relates to the technical field of medicine preparation, in particular to amide compounds and their preparation methods and applications. Background technique [0002] Interferon is a highly active multifunctional glycoprotein produced by macrophages, lymphocytes and somatic cells induced by viruses or other interferons. Interferon acts on the interferon receptors in the cells of animals, and through a series of biochemical processes such as signal transduction, starts the gene synthesis of anti-viral proteins, inhibits the synthesis of viral polypeptide chains, blocks the reproduction of viruses, and prevents viruses from The animal body grows and reproduces, thus playing the role of anti-virus. Interferon has a certain selectivity to the object it acts on, and the animal cells that produce interferon can only inhibit the virus on the same kind or the same kind of animal cells. [0003] At present, exogenous interferon is mainly used fo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D519/00A61P31/16A61P31/14A61P31/12A61P1/00A61P1/12A61K31/437A23K20/137A23K50/30
CPCC07D519/00A61P31/16A61P31/14A61P31/12A61P1/00A61P1/12A23K50/30A23K20/137
Inventor 不公告发明人
Owner 嘉兴金派特生物科技有限公司